Annual SGA
$10.94 M
-$1.53 M-12.27%
December 31, 2023
Summary
- As of February 7, 2025, POAI annual SGA is $10.94 million, with the most recent change of -$1.53 million (-12.27%) on December 31, 2023.
- During the last 3 years, POAI annual SGA has risen by +$2500.00 (+0.02%).
- POAI annual SGA is now -12.27% below its all-time high of $12.47 million, reached on December 31, 2022.
Performance
POAI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.83 M
-$592.30 K-24.46%
September 30, 2024
Summary
- As of February 7, 2025, POAI quarterly SGA is $1.83 million, with the most recent change of -$592.30 thousand (-24.46%) on September 30, 2024.
- Over the past year, POAI quarterly SGA has dropped by -$592.30 thousand (-24.46%).
- POAI quarterly SGA is now -54.21% below its all-time high of $4.00 million, reached on June 30, 2019.
Performance
POAI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$693.16 M
-$13.97 M-2.06%
September 30, 2024
Summary
- As of February 7, 2025, POAI TTM SGA is -$693.16 million, with the most recent change of -$13.97 million (-2.06%) on September 30, 2024.
- Over the past year, POAI TTM SGA has dropped by -$704.48 million (-6225.82%).
- POAI TTM SGA is now -21948.52% below its all-time high of -$3.14 million.
Performance
POAI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
POAI Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.3% | -24.5% | -6225.8% |
| 3 y3 years | +0.0% | -41.6% | -5546.2% |
| 5 y5 years | +56.4% | -41.6% | -5546.2% |
POAI Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.3% | at low | -52.5% | at low | -45.8% | at low |
| 5 y | 5-year | -12.3% | +0.0% | -52.5% | at low | -145.1% | at low |
| alltime | all time | -12.3% | +709.1% | -54.2% | +2057.2% | <-9999.0% | at low |
Predictive Oncology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.83 M(-24.5%) | $10.47 M(-7.5%) |
| Jun 2024 | - | $2.42 M(-24.6%) | $11.32 M(-5.9%) |
| Mar 2024 | - | $3.21 M(+6.9%) | $12.03 M(+6.5%) |
| Dec 2023 | $10.94 M(-12.3%) | $3.00 M(+12.1%) | $11.29 M(-4.2%) |
| Sep 2023 | - | $2.68 M(-14.5%) | $11.79 M(-7.4%) |
| Jun 2023 | - | $3.13 M(+26.6%) | $12.73 M(+4.2%) |
| Mar 2023 | - | $2.48 M(-29.2%) | $12.22 M(-2.0%) |
| Dec 2022 | $12.47 M(+6.5%) | $3.50 M(-3.4%) | $12.47 M(-2.7%) |
| Sep 2022 | - | $3.62 M(+38.1%) | $12.82 M(+12.1%) |
| Jun 2022 | - | $2.62 M(-3.9%) | $11.43 M(+3.5%) |
| Mar 2022 | - | $2.73 M(-29.1%) | $11.05 M(-5.6%) |
| Dec 2021 | $11.71 M(+7.0%) | $3.85 M(+72.3%) | $11.71 M(+17.0%) |
| Sep 2021 | - | $2.23 M(-0.2%) | $10.01 M(-1.1%) |
| Jun 2021 | - | $2.24 M(-33.9%) | $10.12 M(-9.9%) |
| Mar 2021 | - | $3.39 M(+57.4%) | $11.23 M(+2.7%) |
| Dec 2020 | $10.94 M(-6.5%) | $2.15 M(-8.4%) | $10.94 M(-3.9%) |
| Sep 2020 | - | $2.35 M(-29.8%) | $11.38 M(-5.8%) |
| Jun 2020 | - | $3.34 M(+8.1%) | $12.08 M(-5.1%) |
| Mar 2020 | - | $3.09 M(+19.2%) | $12.73 M(+8.9%) |
| Dec 2019 | $11.69 M(+67.2%) | $2.59 M(-15.0%) | $11.69 M(+0.3%) |
| Sep 2019 | - | $3.05 M(-23.6%) | $11.66 M(+16.7%) |
| Jun 2019 | - | $4.00 M(+94.7%) | $9.99 M(+37.2%) |
| Mar 2019 | - | $2.05 M(-19.9%) | $7.28 M(+3.7%) |
| Dec 2018 | $7.00 M(+36.0%) | $2.56 M(+85.1%) | $7.02 M(+41.7%) |
| Sep 2018 | - | $1.38 M(+7.8%) | $4.96 M(+10.2%) |
| Jun 2018 | - | $1.28 M(-28.4%) | $4.50 M(-23.0%) |
| Mar 2018 | - | $1.79 M(+261.0%) | $5.84 M(+5.7%) |
| Dec 2017 | $5.15 M(-24.3%) | $496.60 K(-46.2%) | $5.53 M(-18.7%) |
| Sep 2017 | - | $923.40 K(-64.9%) | $6.80 M(+0.8%) |
| Jun 2017 | - | $2.63 M(+77.6%) | $6.75 M(+4.1%) |
| Mar 2017 | - | $1.48 M(-16.3%) | $6.48 M(-4.7%) |
| Dec 2016 | $6.80 M | $1.77 M(+103.0%) | $6.80 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $870.90 K(-63.2%) | $6.91 M(-0.8%) |
| Jun 2016 | - | $2.37 M(+31.6%) | $6.96 M(+24.5%) |
| Mar 2016 | - | $1.80 M(-4.1%) | $5.59 M(+44.1%) |
| Dec 2015 | $3.90 M(-44.5%) | $1.87 M(+102.0%) | $3.88 M(-7.7%) |
| Sep 2015 | - | $927.80 K(-6.8%) | $4.21 M(-7.0%) |
| Jun 2015 | - | $995.20 K(+1073.6%) | $4.52 M(-17.3%) |
| Mar 2015 | - | $84.80 K(-96.1%) | $5.47 M(-22.2%) |
| Dec 2014 | $7.03 M(-23.6%) | $2.20 M(+76.4%) | $7.03 M(+0.3%) |
| Sep 2014 | - | $1.25 M(-35.8%) | $7.01 M(-26.0%) |
| Jun 2014 | - | $1.94 M(+17.7%) | $9.48 M(+8.5%) |
| Mar 2014 | - | $1.65 M(-24.3%) | $8.74 M(-5.0%) |
| Dec 2013 | $9.21 M(+27.5%) | $2.18 M(-41.4%) | $9.21 M(+6.8%) |
| Sep 2013 | - | $3.71 M(+209.1%) | $8.62 M(+11.4%) |
| Jun 2013 | - | $1.20 M(-43.1%) | $7.74 M(-10.7%) |
| Mar 2013 | - | $2.11 M(+32.7%) | $8.66 M(+20.0%) |
| Dec 2012 | $7.22 M(+74.1%) | $1.59 M(-43.8%) | $7.22 M(-12.0%) |
| Sep 2012 | - | $2.83 M(+33.1%) | $8.21 M(+36.8%) |
| Jun 2012 | - | $2.13 M(+219.0%) | $6.00 M(+36.7%) |
| Mar 2012 | - | $667.40 K(-74.1%) | $4.39 M(+5.9%) |
| Dec 2011 | $4.15 M(+76.3%) | $2.58 M(+312.6%) | $4.15 M(+87.7%) |
| Sep 2011 | - | $625.20 K(+21.0%) | $2.21 M(+10.4%) |
| Jun 2011 | - | $516.90 K(+21.8%) | $2.00 M(+0.5%) |
| Mar 2011 | - | $424.30 K(-33.9%) | $1.99 M(-15.4%) |
| Dec 2010 | $2.35 M(+17.2%) | $642.30 K(+53.8%) | $2.35 M(+19.0%) |
| Sep 2010 | - | $417.50 K(-17.5%) | $1.98 M(-10.8%) |
| Jun 2010 | - | $506.10 K(-35.5%) | $2.22 M(-8.4%) |
| Mar 2010 | - | $785.20 K(+193.4%) | $2.42 M(+20.7%) |
| Dec 2009 | $2.01 M(+48.3%) | $267.60 K(-59.3%) | $2.01 M(-10.4%) |
| Sep 2009 | - | $657.80 K(-7.4%) | $2.24 M(+10.6%) |
| Jun 2009 | - | $710.30 K(+92.1%) | $2.02 M(+54.1%) |
| Mar 2009 | - | $369.80 K(-25.9%) | $1.31 M(+39.2%) |
| Dec 2008 | $1.35 M | $499.30 K(+12.6%) | $942.70 K(+112.6%) |
| Sep 2008 | - | $443.40 K | $443.40 K |
FAQ
- What is Predictive Oncology annual SGA?
- What is the all time high annual SGA for Predictive Oncology?
- What is Predictive Oncology annual SGA year-on-year change?
- What is Predictive Oncology quarterly SGA?
- What is the all time high quarterly SGA for Predictive Oncology?
- What is Predictive Oncology quarterly SGA year-on-year change?
- What is Predictive Oncology TTM SGA?
- What is the all time high TTM SGA for Predictive Oncology?
- What is Predictive Oncology TTM SGA year-on-year change?
What is Predictive Oncology annual SGA?
The current annual SGA of POAI is $10.94 M
What is the all time high annual SGA for Predictive Oncology?
Predictive Oncology all-time high annual SGA is $12.47 M
What is Predictive Oncology annual SGA year-on-year change?
Over the past year, POAI annual SGA has changed by -$1.53 M (-12.27%)
What is Predictive Oncology quarterly SGA?
The current quarterly SGA of POAI is $1.83 M
What is the all time high quarterly SGA for Predictive Oncology?
Predictive Oncology all-time high quarterly SGA is $4.00 M
What is Predictive Oncology quarterly SGA year-on-year change?
Over the past year, POAI quarterly SGA has changed by -$592.30 K (-24.46%)
What is Predictive Oncology TTM SGA?
The current TTM SGA of POAI is -$693.16 M
What is the all time high TTM SGA for Predictive Oncology?
Predictive Oncology all-time high TTM SGA is -$3.14 M
What is Predictive Oncology TTM SGA year-on-year change?
Over the past year, POAI TTM SGA has changed by -$704.48 M (-6225.82%)